跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
tuberculosis vaccine
首页
药物
tuberculosis vaccine
tuberculosis vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Tuberculosis vaccine with improved efficacy
US 7988980 B2
申请人: MAX PLANCK GESELLSCHAFT
优先权: 2004
CN
US
5 件公开
Tuberculosis vaccine and method of using same
US 8394389 B2
申请人: LIGHTER JENNIFER
优先权: 2008
US
5 件公开
TUBERCULOSIS VACCINE COMPOSITION CONTAINING IMMUNE-ACTIVE SITE FUSION PROTEIN
EP 4541370 A1
申请人: MYCO RAPHA INC
优先权: 2022
CN
EP
US
WO
4 件公开
VACCINE CONSTRUCTS COMPRISING TUBERCULOSIS ANTIGENS
EP 4561617 A1
申请人: UNIV CAPE TOWN
优先权: 2022
CN
EP
US
WO
4 件公开
NANOPARTICLE VACCINE FOR PREVENTING MYCOBACTERIUM TUBERCULOSIS INFECTION AND PREPARATION METHOD THEREFOR
EP 4803097 A1
申请人: YANTAI PATRONUS BIOTECH CO LTD
优先权: 2023
CN
EP
WO
4 件公开
Tuberculosis vaccine
US 8287886 B2
申请人: MONTANES CARLOS MARTIN
优先权: 2006
US
4 件公开
US 2002131976 A1
申请人: LALVANI AJIT
优先权: 2001
US
2 件公开
US 2002177569 A1
申请人: KAUFMANN STEFAN H E
优先权: 2001
US
2 件公开
US 6673353 B1
申请人: MAX PLANCK GESELLSCHAFT
优先权: 1997
US
CN 118510791 A
申请人: VIR BIOTECH INC
优先权: 2022
CN
Tuberculosis TB vaccine to prevent reactivation
US 9074001 B2
申请人: DIETRICH JES
优先权: 2009
US
4 件公开
INTRANASAL SPRAY-TYPE TUBERCULOSIS VACCINE USING PARAMYXOVIRUS VECTOR
US 2012219582 A1
申请人: YASUTOMI YASUHIRO
优先权: 2009
CN
EP
US
3 件公开
NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS
EP 4482851 A4
申请人: UNIV CALIFORNIA
优先权: 2022
EP
US
WO
3 件公开
USE OF BCG GENE BCG_1820 IN PREPARING TUBERCULOSIS VACCINE RECOMBINANT BCG
EP 4484551 A4
申请人: SHANGHAI PULMONARY HOSPITAL
优先权: 2022
CN
EP
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈